SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION

Projektinformationen

PvSTATEM

ID Finanzhilfevereinbarung: 101057665

DOI

10.3030/101057665

EK-Unterschriftsdatum 24 Mai 2022

Startdatum 1 Oktober 2022

Enddatum 30 September 2027

Finanziert unter

• Health

Gesamtkosten

€ 7 290 778,13

EU-Beitrag

€ 7 290 778,13

Koordiniert durch

INSTITUT PASTEUR
France

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (13)

Consortium agreement accession form for PW

The Hop On beneficiary, i.e. PW, will accede the Consortium Agreement.

Health systems analysis: Ethiopia

Report on epidemiological analysis of health systems data at trial site

Safety report: Madagascar

PvSeroTAT safety report

Study initiation
Training manual
Baseline screening report

Report on baseline screening and randomisation

Laboratory training report

A report documenting the training materials provided to Ethiopian and Malagasy laboratory personnel (M12).

Health systems analysis: Madagascar

Report on epidemiological analysis of health systems data at trial site

mHealth strategy report

mHealth strategy report, including mapping of behaviour change techniques/intervention functions onto prototype app development (M12)

Midterm recruitment
Internship training reports
Collective intelligence report
Rapid assessment report

Websites, patent fillings, videos etc. (1)

Project website

Other (2)

Independent boards

External Scientific and Advisory Committee (ESAC) and Data and Safety Monitoring Board (DSMB) - A report on the constitution of the ESAC and Independent DSMB will be prepared (M06)

Statistical analysis plan

Statistical Analysis plan